By Eric Levin, CEO, Scripta Insights   2026 is shaping up to be one of the most consequential years in pharmacy benefits in decades. Costs are accelerating. New channels are exploding. And GLP-1s are rewriting every budget model in HR and finance.   One of the biggest operational headaches will be something most plans are not prepared for:  helping members navigate the growing confusion caused by cash-pay and direct-to-consumer (DTC) drug programs.  With TrumpRx and others pr

The pharmacy and benefits landscape has become too complex for manual processes alone. Between high-velocity drug launches, opaque pricing models, shifting formularies, and unstructured regulatory data, teams navigating pharmacy decisions need stronger tools. Artificial intelligence, when used responsibly, can dramatically improve the speed, accuracy, and consistency of Rx Navigation workflows. But like any powerful technology, it comes with guardrails. Below are the key do’s

The pharmacy benefits landscape is shifting faster than ever. Between policy changes, new market dynamics, and breakthrough medications, benefits leaders are navigating unprecedented complexity. Here are the top questions we're hearing from plan sponsors – and the answers you need now. Q: How will TrumpRx affect our pharmacy costs and benefit design?   A:  TrumpRx could reshape the prescription drug landscape in three significant ways. First, by tying U.S. drug prices to inte